Human medicines European public assessment report (EPAR): Qezzaqar, catequentinib, Status: Opinion

RegulatoryQezzaqarNeutral

AI Analysis

Summary

The European Medicines Agency has released a public assessment report for Qezzaqar (catequentinib) at the opinion stage, indicating progression through the European regulatory review process.

Outcome Details

Opinion phase of European public assessment report

Importance:5/10

Sentiment:

0.00

EMAEPARregulatoryEuropean approval pathway

Read the original article

Published by EMA New Human Medicines on September 9, 2026 7:03 AM

Read Original